Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children

Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children This essay discusses a shift toward trial designs based on master protocols, which could expedite the development of tumor-agnostic drugs for children. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children

Loading next page...
 
/lp/american-medical-association/master-protocols-and-adaptive-trial-designs-to-develop-tumor-agnostic-hg8haR2Vc5
Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2021.1508
Publisher site
See Article on Publisher Site

Abstract

This essay discusses a shift toward trial designs based on master protocols, which could expedite the development of tumor-agnostic drugs for children.

Journal

JAMA OncologyAmerican Medical Association

Published: Sep 10, 2021

References